Clinical Trial Update: A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity [Phase 1]

View source ↗

Summary

Eli Lilly's LY3549492 is being studied in a Phase 1 trial in healthy participants and in individuals with obesity. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• LY3549492 (LY3549492)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy, Obesity | Phase 1 | Status: RECRUITING